Xenetic Biosciences, Inc.盘中异动股价大跌5.08%报4.11美元

自选股智能写手04-15

北京时间2024年04月15日21时30分，Xenetic Biosciences, Inc.（XBIO.us）股票出现异动，股价快速跳水5.08%。截至发稿，该股报4.11美元/股，成交量12股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入2.54百万美元，净利润-4.13百万美元，每股收益-2.71美元，毛利--，市盈率-1.59倍。机构评级方面，目前暂无机构对该股...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2427006187?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-15 21:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2427006187","market":"us","top_or_hot":-1,"title":"Xenetic Biosciences, Inc.盘中异动 股价大跌5.08%报4.11美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月15日21时30分，Xenetic Biosciences, Inc.（XBIO.us）股票出现异动，股价快速跳水5.08%。截至发稿，该股报4.11美元/股，成交量12股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入2.54百万美元，净利润-4.13百万美元，每股收益-2.71美元，毛利--，市盈率-1.59倍。机构评级方面，目前暂无机构对该股...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213043861e5cbd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xenetic Biosciences, Inc.盘中异动 股价大跌5.08%报4.11美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXenetic Biosciences, Inc.盘中异动 股价大跌5.08%报4.11美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-15 21:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213043861e5cbd&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月15日21时30分，Xenetic Biosciences, Inc.（XBIO.us）股票出现异动，股价快速跳水5.08%。截至发稿，该股报4.11美元/股，成交量12股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入2.54百万美元，净利润-4.13百万美元，每股收益-2.71美元，毛利--，市盈率-1.59倍。机构评级方面，目前暂无机构对该股...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213043861e5cbd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213043861e5cbd&s=b","article_id":"2427006187","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213043861e5cbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2427006187","pubTimestamp":1713187843,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月15日21时30分，Xenetic Biosciences, Inc.股票出现异动，股价快速跳水5.08%。Xenetic Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.34%。其相关个股中，Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大，Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为575.26%、327.00%、246.72%，振幅较大的相关个股有Pluri Inc.、Sol-Gel Technologies Ltd.、Cg Oncology, Inc.，振幅分别为6.96%、6.78%、5.19%。Xenetic Biosciences, Inc.公司简介：Xenetic Biosciences Inc是一家专注于XCART的生物制药公司，XCART是一种个性化的CAR T平台技术，专门针对患者特定的肿瘤新抗原。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","XBIO":"Xenetic Biosciences Inc","XBIOW":"Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com)"},"translate_title":"Xenetic Biosciences, Inc. shares fell 5.08% to $4.11 in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBIOW":1,"XBIO":0.9},"content_text":"北京时间2024年04月15日21时30分，Xenetic Biosciences, Inc.（XBIO.us）股票出现异动，股价快速跳水5.08%。截至发稿，该股报4.11美元/股，成交量12股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入2.54百万美元，净利润-4.13百万美元，每股收益-2.71美元，毛利--，市盈率-1.59倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xenetic Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.34%。其相关个股中，Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大，Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为575.26%、327.00%、246.72%，振幅较大的相关个股有Pluri Inc.、Sol-Gel Technologies Ltd.、Cg Oncology, Inc.，振幅分别为6.96%、6.78%、5.19%。Xenetic Biosciences, Inc.公司简介：Xenetic Biosciences Inc是一家专注于XCART的生物制药公司，XCART是一种个性化的CAR T平台技术，专门针对患者特定的肿瘤新抗原。该公司最初正在推进基于细胞的疗法，针对个别患者恶性肿瘤细胞表面的B细胞受体，用于治疗B细胞淋巴瘤。XCART有可能推动针对肿瘤学适应症的治疗资产管道。该公司还拥有用于治疗孕激素耐药性子宫内膜癌的肿瘤治疗研究候选药物XBIO-101。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2427006187"}

Xenetic Biosciences, Inc.盘中异动 股价大跌5.08%报4.11美元

精彩评论

Xenetic Biosciences, Inc.盘中异动股价大跌5.08%报4.11美元